共 50 条
- [21] Rituximab, Omalizumab, and Dupilumab Treatment Outcomes in Bullous Pemphigoid: A Systematic Review FRONTIERS IN IMMUNOLOGY, 2022, 13
- [22] Dramatic exacerbation of bullous pemphigoid following rituximab and successful treatment with omalizumab European Journal of Dermatology, 2019, 29 : 213 - 215
- [25] Rituximab for Acquired Hemophilia A in the Setting of Bullous Pemphigoid CUTIS, 2022, 110 (01): : E23 - E24
- [26] Efficacy of rituximab in a case of refractory bullous pemphigoid ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2009, 136 (05): : 431 - 434
- [28] Adjuvant treatment of severe/refractory bullous pemphigoid with protein A immunoadsorption JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2018, 16 (09): : 1109 - 1118
- [30] Clinical effect of omalizumab as an adjuvant treatment to rituximab in patient with refractory bullous pemphigoid JOURNAL OF DERMATOLOGY, 2023, 50 (05): : 705 - 709